Cleveland BioLabs

Cleveland BioLabs

Employees:
20
Market Cap:
$24.96 million
Revenue:
$3.76 million
5 Year Trend:
16.7%
Net Income:
$-5.04 million
NASDAQ:
CBLI

Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. Wikipedia

Cleveland BioLabs

Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. Wikipedia

Employees:
20
Market Cap:
$24.96 million
Revenue:
$3.76 million
5 Year Trend:
16.7%
Net Income:
$-5.04 million
NASDAQ:
CBLI